Active Management of the Third Stage of Labour without Controlled Cord Traction : A Randomized Non-Inferiority Controlled Trial

Show simple item record

dc.contributor.author
Gulmezoglu, A. M.
en_US
dc.contributor.author
Widmer, M.
en_US
dc.contributor.author
Merialdi, M.
en_US
dc.contributor.author
Qureshi, Z.
en_US
dc.contributor.author
Piaggio, G.
en_US
dc.contributor.author
Elbourne, D.
en_US
dc.contributor.author
Abdel-Aleem, H.
en_US
dc.contributor.author
Carroli, G.
en_US
dc.contributor.author
Hofmeyr, G. J.
en_US
dc.contributor.author
Lumbiganon, P.
en_US
dc.contributor.author
Derman, R.
en_US
dc.contributor.author
Okong, P.
en_US
dc.contributor.author
Goudar, S.
en_US
dc.contributor.author
Festin, M.
en_US
dc.contributor.author
Althabe, F.
en_US
dc.contributor.author
Armbruster, D.
en_US
dc.date.accessioned
2012-03-30T07:31:14Z
en_US
dc.date.available
2012-03-30T07:31:14Z
en_US
dc.date.issued
2009
en_US
dc.identifier.citation
Reprod Health
en_US
dc.identifier.issn
1742-4755 (Electronic) 1742-4755 (Linking)
en_US
dc.identifier.uri
http://hdl.handle.net/10986/5090
en_US
dc.description.abstract
BACKGROUND: The third stage of labour refers to the period between birth of the baby and complete expulsion of the placenta. Some degree of blood loss occurs after the birth of the baby due to separation of the placenta. This period is a risky period because uterus may not contract well after birth and heavy blood loss can endanger the life of the mother. Active management of the third stage of labour (AMTSL) reduces the occurrence of severe postpartum haemorrhage by approximately 60-70%. Active management consists of several interventions packaged together and the relative contribution of each of the components is unknown. Controlled cord traction is one of those components that require training in manual skill for it to be performed appropriately. If it is possible to dispense with controlled cord traction without losing efficacy it would have major implications for effective management of the third stage of labour at peripheral levels of health care. OBJECTIVE: The primary objective is to determine whether the simplified package of oxytocin 10 IU IM/IV is not less effective than the full AMTSL package. METHODS: A hospital-based, multicentre, individually randomized controlled trial is proposed. The hypothesis tested will be a non-inferiority hypothesis. The aim will be to determine whether the simplified package without CCT, with the advantage of not requiring training to acquire the manual skill to perform this task, is not less effective than the full AMTSL package with regard to reducing blood loss in the third stage of labour.The simplified package will include uterotonic (oxytocin 10 IU IM) injection after delivery of the baby and cord clamping and cutting at approximately 3 minutes after birth. The full package will include the uterotonic injection (oxytocin 10 IU IM), controlled cord traction following observation of uterine contraction and cord clamping and cutting at approximately 3 minutes after birth. The primary outcome measure is blood loss of 1000 ml or more at one hour and up to two hours for women who continue to bleed after one hour. The secondary outcomes are blood transfusion, the use of additional uterotonics and measure of severe morbidity and maternal death.We aim to recruit 25,000 women delivering vaginally in health facilities in eight countries within a 12 month recruitment period. MANAGEMENT: Overall trial management will be from HRP/RHR in Geneva. There will be eight centres located in Argentina, Egypt, India, Kenya, Philippines, South Africa, Thailand and Uganda. There will be an online data entry system managed from HRP/RHR. The trial protocol was developed following a technical consultation with international organizations and leading researchers in the field. EXPECTED OUTCOMES: The main objective of this trial is to investigate whether a simplified package of third stage management can be recommended without increasing the risk of PPH. By avoiding the need for a manual procedure that requires training, the third stage management can be implemented in a more widespread and cost-effective way around the world even at the most peripheral levels of the health care system. This trial forms part of the programme of work to reduce maternal deaths due to postpartum haemorrhage within the RHR department in collaboration with other research groups and organizations active in the field. TRIAL REGISTRATION: ACTRN12608000434392.
en_US
dc.language.iso
EN
en_US
dc.relation.uri
http://creativecommons.org/licenses/by-nc-nd/3.0/igo
en_US
dc.title
Active Management of the Third Stage of Labour without Controlled Cord Traction : A Randomized Non-Inferiority Controlled Trial
en_US
dc.title.alternative
Reprod Health
en_US
dc.type
Journal Article
en_US
okr.identifier.externaldocumentum
1794
en_US
okr.identifier.internaldocumentum
19154621
en_US
okr.volume
6
en_US
okr.identifier.doi
10.1186/1742-4755-6-2
en_US
okr.doctype
Journal Article
en_US
dc.rights.holder
World Bank
en_US
okr.peerreview
Academic Peer Review
en_US
okr.relation.associatedurl
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19154621
en_US
okr.externalcontent
External Content
en_US
okr.journal.nbpages
2
en_US
okr.googlescholar.linkpresent
yes

Show simple item record



Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)